Published in Hospital Business Week, March 7th, 2004
The company offers HSAs among its products.
"We're encouraged by the level of interest in HSAs this study reveals because we believe the potential role HSAs can play in curbing skyrocketing healthcare costs is huge," said Scott Spiker, CEO of Destiny Health. "However, it's clear that consumer education is vital for their full power to be reached because HSAs alone cannot change consumer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.